Unresectable hilar cholangiocarcinoma: Multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy

In Vivo

Volumn 20, Issue 6 A, 2006, Pages 757-760

  Golfieri, Rita ^a   Giampalma, E ^a   Renzulli, M ^a   Galuppi, A ^a   Vicenzi, L ^a   Galaverni, M C ^a   Cappelli, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Biliary tract neoplasms; Brachytherapy; Expandable metallic stents; Iridium radioisotopes; Radiotherapy

Indexed keywords

FLUOROURACIL; IRIDIUM 192;

ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT DRAINAGE; BILIARY TRACT SURGERY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CHOLANGIOGRAPHY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DECOMPRESSION SURGERY; DIGESTIVE SYSTEM HEMORRHAGE; ENDOPROSTHESIS; ENDOSCOPIC THERAPY; HOSPITALIZATION; HUMAN; INOPERABLE CANCER; LIVER ABSCESS; MULTIMODALITY CANCER THERAPY; STENT; SURVIVAL TIME;

EID: 33846103088     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bismuth H and Malt RA: Carcinoma of the biliary tract. N Eng J Med 331: 704-706, 1979.
2. Henson DE, Albores-Saavedra J and Corle D: Carcinoma of the extrahepatic bile ducts: histologic types, stage of disease, grade, and survival rates. Cancer 70(6): 1498-1501, 1992.
3. Righi D, Garretti L, Zanon E, Gazzera C, Cristoferi M and Gandini G: Trattamento percutaneo del colangiocarcinoma ilare completato con brachiterapia con alto rateo di dose. Radiol Med 88: 79-85, 1994.
4. Klatskin G: Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 38: 241-256, 1965.
5. Langer JC, Langer B, Taylor BR, Zeldin R and Cummings B: Carcinoma of the extrahepatic bile ducts: result of an a aggressive approach. Surgery 98: 752-759, 1985.
6. Lee CK, Barrios BR and Bjarnason H: Biliary tree malignancies: the University of Minnesota experience. J Surg Oncol 65(4): 298-305, 1997.
7. Tsao JI, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, Miyachi M, Kanai M, Uesaka K, Oda K, Rossi RL, Braasch JW and Dugan JM: Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg 232(2): 166-174, 2000.
8. Kamada T, Saitou H, Takamura A, Nojima T and Okushiba SI: The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiation Oncology Biol Phys 34: 767-774, 1996.
9. Kuvshinoff BW, Armstrong JG, Fong Y, Schupak K, Getradjman G, Heffernan N and Blumgart LH: Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. British J Surgery 82: 1522-1525, 1995.
10. Karani J, Fletcher M, Brinkley D, Dawson JL, Williams R and Nunnerley H: Internal biliary drainage and local radiotherapy with Ir-192 wire in treatment of hilar cholangiocarcinoma. Clin Radiol 36: 603-606, 1985.
11. Leung J, Guiney M and Das R: Intraluminal brachytherapy in bile duct carcinomas. Aust NZ J Surg 66(2): 74-77, 1996.
12. Milella M, Salvetti M, Cerrotta A, Cozzi G, Uslenghi E, Tavola A, Gardani G and Severini A: Interventional radiology and radiotherapy for inoperable cholangiocarcinoma of the extrahepatic bile ducts. Tumori 84(4): 467-471, 1998.
13. Singhal D, van Gulik TM and Gouma DJ: Palliative management of hilar cholangiocarcinoma. Surgical Oncology 14: 59-74, 2005.
14. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Thursz MR and Wasan H: British Society of Gastroenterology: Guidelines for the diagnosis and treatment of cholangio-carcinoma: consensus document. Gut 51(6): VI1-9, 2002.
15. Gonzalez Gonzalez D, Gouma D J, Rauws EA, van Gulik TM, Bosma A and Koedooder C: Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma. Annals of Oncology 10(4): 215-220, 1999.
16. Takamura A, Saito H, Kamada T, Hiramatsu K, Takeuchi S, Hasegawa M and Miyamoto N: Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 57(5): 1357-1365, 2003.
17. McMasters KM, Tuttle TM, Leach SD, Rich T, Cleary KR, Evans DB and Curley SA: Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 174(6): 605-608, 1997.
18. Foo ML, Gunderson LL, Bender CE and Buskirk SJ: External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 39(4): 929-935, 1997.
19. Morganti AG, Trodella L, Valentini V, Montemaggi P, Costamagna G, Smaniotto D, Luzi S, Ziccarelli P, Macchia G, Perri V, Mutignani M and Cellini N: Combined modality treatment in unresectable extrahepatic biliary carcinoma. Int J Radiat Oncol Biol Plays 46(4): 913-919, 2000.
20. Golfieri R, Giampalma E, Muzzi C, Maffei M, Amore B, Grazia C, Frezza G, Galuppi A and Gavelli G: Unresectable hilar cholangiocarcinoma: combined percutaneous and radiotherapic treatment. Radiol Med 101(6): 495-502, 2001.
21. Bruha R, Petrtyl J, Kubecova M, Marecek Z, Dufek V, Urbanek P, Kodadova J and Chodounsky Z: Intraluminal brachytherapy and self expandable stents in nonresectable biliary malignancies - the question of long-term palliation. Hepatogastroenterology 48(39): 631-637, 2001.
22. Gerhards MF, van Gulik TM, Gonzalez Gonzalez D, Rauws EA and Gouma DJ: Results of postoperative radiotherapy for resectable hilar cholagiocarcinoma. World J Surg 27(2): 173-179, 2003.